Clinical Trial Update: Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial results report preliminary efficacy and safety for ST101 in combination with Aricept (donepezil) in Alzheimer's disease. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Aricept (Donepezil)
• ST101 (ST101)

Snippet

Sponsor: Sonexa Therapeutics, Inc. | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED